- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01058187
Assessment of Fatty Acids in Infants' Blood Cells When Consuming Infant Formula Containing Long-Chain Polyunsaturated Fatty Acids
March 10, 2014 updated by: Mead Johnson Nutrition
To compare amounts of DHA, ARA, and other fatty acids in the blood cells of infants consuming infant formulas containing differing levels of fatty acids
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Anticipated)
86
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G2P5
- Alberta Institute for Human Nutrition, University of Alberta
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 3 weeks (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Infants 12-25 days of age
Description
Inclusion Criteria:
- Singleton birth
- 12-25 days of age
- Gestational age of 37-42 weeks
- Solely formula fed for at least 24 hours prior to randomization
- Birth weight 2500 g - 4000 g
Exclusion Criteria:
- Serious concurrent illness or congenital malformation
- Systemic or congenital infection
- Immunocompromised
- History of intolerance or allergy to cow milk
- Maternal autoimmune disorder
- Participation in another clinical study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Control
Marketed cow milk-based infant formula containing DHA and ARA
|
|
Investigational 1
Cow milk-based infant formula with differing level of ARA from Control formula
|
|
Investigational 2
Cow milk-based infant formula with a differing level of ARA from Control
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tom Clandinin, Ph.D., University of Alberta
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
May 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
January 26, 2010
First Submitted That Met QC Criteria
January 27, 2010
First Posted (Estimate)
January 28, 2010
Study Record Updates
Last Update Posted (Estimate)
March 12, 2014
Last Update Submitted That Met QC Criteria
March 10, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- 6000
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Levels of Fatty Acids in the Blood Cells of Infants
-
Mead Johnson NutritionCompletedLevels of DHA in the BloodUnited States
-
Hacettepe UniversityCompletedThe Aim of This Study is to Evaluate the Effects of Acute Exercise on Serum Oncostatin M Levels in Healthy, Recreationally Active MalesTurkey (Türkiye)
-
Supplement Formulators, Inc.CompletedIncrease in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+)United States
-
Menoufia UniversityNot yet recruitingPain Scores | Change in Serum Levels of the Estimated Inflammatory Cytokines | Total Dose of IO Fentanyl | PO Morphine | Surgeons' RatingEgypt
-
All India Institute of Medical Sciences, New DelhiIndian Council of Medical ResearchUnknownHoming of Stem Cells in the Infarct Area.India
-
Meshalkin Research Institute of Pathology of CirculationNot yet recruitingthe Strength Properties of the Aorta in Vivo | the Strength Properties of the Aorta in Vitro | Regression Model of Aortic Strength Properties in Vitro and in VitroRussian Federation
-
Institute of Medical Biology, Chinese Academy of...Guangxi Center for Disease Control and PreventionCompletedThe Efficacy of Inactivated EV71 Vaccine (KMB17) Against HFMD in Chinese Children and InfantsChina
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaboratorsCompletedThe Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy VolunteersFrance
-
Shandong New Time Pharmaceutical Co., LTDCompletedA Phase IV Trial to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty LiverChina
-
National Taiwan University HospitalUnknownthe Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in LiverTaiwan